Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2019
Price : $35 *
At a glance
- Drugs Aramchol (Primary) ; Atorvastatin; Midazolam
- Indications Cholelithiasis; Lipodystrophy; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Galmed Pharmaceuticals
- 03 Apr 2019 Status changed from active, no longer recruiting to completed.
- 10 Feb 2019 Planned End Date changed from 1 Feb 2019 to 1 Mar 2019.
- 07 Dec 2018 New trial record